Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
263,431
-
Share change
-
+474
-
Total reported value
-
$1,958,000
-
Price per share
-
$7.43
-
Number of holders
-
21
-
Value change
-
+$6,399
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2018
As of 30 Jun 2018,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
263,431 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BARCLAYS PLC, MORGAN STANLEY, BlackRock Inc., PNC Financial Services Group, Inc., GLENMEDE TRUST CO NA, DEUTSCHE BANK AG\, Rossmore Private Capital, WELLS FARGO & COMPANY/MN, and UBS Group AG.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.